blog | Blossomhill Therapeutics

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, 2026, Blossomhill Therapeutics, Latigo Biotherapeutics

Summer Doldrums Set In as Latigo (LTGO) and BlossomHill (BLSM) Close Out a Quieter Week for the IPO Market

Eric Friedman

Aug 7, 2026, 4:44:49 PM

The IPO market showed signs of its traditional late-summer slowdown Friday as Latigo Biotherapeutics...

IPOs, 2026, Blossomhill Therapeutics

BlossomHill Therapeutics (BLSM) Targets $125 Million IPO to Advance Precision Oncology Pipeline Built on Next-Generation Small Molecule Design

Eric Friedman

Aug 3, 2026, 4:00:36 PM

San Diego-based BlossomHill Therapeutics has filed for a Nasdaq IPO seeking to raise approximately $...

Subscribe to our Newsletter

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025